Empagliflozin vs Trastuzumab Deruxtecan

## Empagliflozin vs Trastuzumab Deruxtecan: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Trastuzumab Deruxtecan**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Trastuzumab Deruxtecan — N/A.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Trastuzumab Deruxtecan — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Trastuzumab Deruxtecan — N/A.

**Type**: Empagliflozin — Small molecule; Trastuzumab Deruxtecan — Antibody drug conjugate.